Safae Karim, Chahrazed Bouchikhi, Abdelaziz Banani, Hinde E L Fatemi, Tiatou Souho, Sanaa Erraghay, Bahia Bennani
{"title":"Detection of <i>Ureaplasma</i> Biovars and Subtyping of <i>Ureaplasma parvum</i> among Women Referring to a University Hospital in Morocco.","authors":"Safae Karim, Chahrazed Bouchikhi, Abdelaziz Banani, Hinde E L Fatemi, Tiatou Souho, Sanaa Erraghay, Bahia Bennani","doi":"10.1155/2020/7286820","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to determine the prevalence of <i>Ureaplasma</i> biovars and <i>Ureaplasma parvum</i> (<i>U. parvum</i>) serovars, their associated risk factors, and genital STI-related symptoms.</p><p><strong>Methods: </strong>DNA obtained from cervical samples of 1053 women attending the department of Obstetrics and Gynecology and the laboratory of pathological anatomy of Hassan II university hospital of Fez, Morocco, was used to detect <i>Ureaplasma</i> biovars (<i>U. urealyticum</i> and <i>U. parvum</i>) and to subtype <i>U. parvum</i> by polymerase chain reaction (PCR).</p><p><strong>Results: </strong>Of the 1053 women examined, 25.4% (268/1053) were <i>Ureaplasma</i> positives. The rates of <i>U. urealyticum</i> and <i>U. parvum</i> were 12.1% (128/1053) and 7% (74/1053), respectively, and the copresence of these biovars was noted in 6.3% (66/1053) cases. The <i>U. parvum</i> subtyping revealed a predominance of the serovar 3/14 (61.4%). The association of demographics variables with <i>Ureaplasma</i> biovars was studied and shows that the age (\"<30\" years) seems to be a risk factor of <i>Ureaplasma</i> spp. and <i>U. urealyticum</i> carriage (OR 1.729, 95% CI [1.113-2.687] and OR 1.848, 95% CI [1.026-3.330], respectively). There was no difference in the prevalence of <i>Ureaplasma</i> type regarding symptoms. However, a significant association was found between <i>U. parvum</i> serovar 1 and infertility (<i>P</i> = 0.011).</p><p><strong>Conclusion: </strong>This first study conducted in Morocco provides an idea on <i>Ureaplasma</i> biovars and <i>U. parvum</i> serovars circulating in this region, their associated risk factors, and genital STI-related symptoms. Therefore, further studies are required to clarify and confirm the pathogenic role of these <i>Ureaplasma</i> species.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"7286820"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7286820","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases in Obstetrics and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/7286820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives: The aim of this study was to determine the prevalence of Ureaplasma biovars and Ureaplasma parvum (U. parvum) serovars, their associated risk factors, and genital STI-related symptoms.
Methods: DNA obtained from cervical samples of 1053 women attending the department of Obstetrics and Gynecology and the laboratory of pathological anatomy of Hassan II university hospital of Fez, Morocco, was used to detect Ureaplasma biovars (U. urealyticum and U. parvum) and to subtype U. parvum by polymerase chain reaction (PCR).
Results: Of the 1053 women examined, 25.4% (268/1053) were Ureaplasma positives. The rates of U. urealyticum and U. parvum were 12.1% (128/1053) and 7% (74/1053), respectively, and the copresence of these biovars was noted in 6.3% (66/1053) cases. The U. parvum subtyping revealed a predominance of the serovar 3/14 (61.4%). The association of demographics variables with Ureaplasma biovars was studied and shows that the age ("<30" years) seems to be a risk factor of Ureaplasma spp. and U. urealyticum carriage (OR 1.729, 95% CI [1.113-2.687] and OR 1.848, 95% CI [1.026-3.330], respectively). There was no difference in the prevalence of Ureaplasma type regarding symptoms. However, a significant association was found between U. parvum serovar 1 and infertility (P = 0.011).
Conclusion: This first study conducted in Morocco provides an idea on Ureaplasma biovars and U. parvum serovars circulating in this region, their associated risk factors, and genital STI-related symptoms. Therefore, further studies are required to clarify and confirm the pathogenic role of these Ureaplasma species.
期刊介绍:
Infectious Diseases in Obstetrics and Gynecology aims to disseminate new and important information to clinicians and other health care providers, scientists, and researchers involved in the study or treatment of infectious diseases, especially those affecting the female patient. Its ultimate aim is to advance knowledge and encourage research, thereby improving the prevention or diagnosis and treatment of patients affected by such diseases.